It's only innate immunity but I like it

Advances in Experimental Medicine and Biology

Volumn 590, Issue , 2007, Pages 89-101

  Marcenaro, Emanuela ^a,b   Della Chiesa, Mariella ^a   Dondero, Alessandra ^a   Ferranti, Bruna ^a   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ALPHA INTERFERON; CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; CELL CONTACT; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; MAST CELL; MOLECULAR INTERACTION; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL;

EID: 84934438666     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-34814-8_6     Document Type: Article

References (66)

1. G. Trinchieri. Biology of natural killer cells. Adv Immunol 47:187-376 (1989).
2. A. Moretta, C. Bottino, M.C. Mingari, R. Biassoni and L. Moretta. What is a natural killer cell? Nat Immunol 3(1):6-8 (2002).
3. A. Moretta, C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R.Biassoni and L. Moretta. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197-223 (2001).
4. E. Vivier, J.A. Nunes and F. Vely. Natural killer cell signaling pathways. Science 306(5701):1517-1519 (2004).
5. A. Moretta, C. Bottino, M.Vitale, D. Pende, R. Biassoni, M.C. Mingari and L. Moretta. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619-648 (1996).
6. E.O. Long. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17:875-904 (1999).
7. M. Lopez-Botet, M. Llano, F. Navarro and T. Bellon. NK cell recognition of nonclassical HLA class I molecules. Semin Immunol 12(2):109-119 (2000).
8. C. Vilches and P. Parham. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20:217-251 (2002).
9. C. Bottino, R. Castriconi, L. Moretta and A. Moretta. Cellular ligands of activating NK receptors. Trends Immunol 26(4):221-226 (2005).
10. A. Cerwenka and L.L. Lanier. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 181:158-169 (2001).
11. D.H. Raulet. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3(10):781-790 (2003).
12. N.C. Fernandez, A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky and L. Zitvogel. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5(4):405-411 (1999).
13. J.L. Wilson, L.C. Heffler, J. Charo, A. Scheynius, M.T. Bejarano and H.G. Ljunggren. Targeting of human dendritic cells by autologous NK cells. J Immunol 163(12):6365-6370 (1999).
14. E. Carbone, G. Terrazzano, G. Ruggiero, D. Zanzi, A. Ottaiano, C. Manzo, K. Karre and S. Zappacosta. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 29(12):4022-4029 (1999).
15. G. Ferlazzo, M.L. Tsang, L. Moretta, G. Melioli, R. M Steinman and C. Munz. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195(3):343-351 (2002).
16. F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra and G. Trinchieri. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195(3):327-333 (2002).
17. D. Piccioli, S. Sbrana, E. Melandri and N.M. Valiante. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195(3):335-341 (2002).
18. M. Vitale, M. Della Chiesa, S. Carlomagno, C. Romagnani, A. Thiel, L. Moretta and A. Moretta. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 34(6):1715-1722 (2004).
19. A. Moretta. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2(12):957-964 (2002).
20. M.A. Cooper, T.A. Fehniger, A. Fuchs, M. Colonna and M.A. Caligiuri. NK cell and DC interactions. Trends Immunol 25(1):47-52 (2004).
21. L. Zitvogel. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 195(3):F9-F14 (2002).
22. D.H. Raulet. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5(10):996-1002 (2004).
23. T. Walzer, M. Dalod, S.H. Robbins, L. Zitvogel and E. Vivier. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106(7):2252-2258 (2005).
24. M. Della Chiesa, S. Sivori, R. Castriconi, E. Marcenaro and A. Moretta. Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol 13(3):128-136 (2005).
25. A. Moretta. The dialogue between human natural killer cells and dendritic cells. Curr Opin Immunol 17(3):306-311 (2005).
26. A. Moretta, E. Marcenaro, S. Sivori, M. Della Chiesa, M. Vitale and L. Moretta. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 26(12):668-675 (2005).
27. S. Sivori, M. Falco, M. Della Chiesa, S. Carlomagno, M. Vitale, L. Moretta and A. Moretta. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101(27):10116- 10121 (2004).
28. K.N. Schmidt, B. Leung, M. Kwong, K.A. Zarember, S. Satyal, T.A. Navas, F. Wang and P.J. Godowski. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172(1):138-143 (2004).
29. S. Pisegna, G. Pirozzi, M. Piccoli, L. Frati, A. Santoni and G. Palmieri. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104(13):4157-4164 (2004).
30. S. Akira and K. Takeda. Toll-like receptor signalling. Nat Rev Immunol 4(7):499-511 (2004).
31. F. Sallusto and A. Lanzavecchia. Mobilizing dendritic cells for tolerance. priming and chronic inflammation. J Exp Med 189(4):611-614 (1999).
32. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran and K. Palucka. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811 (2000).
33. C. Reis e Sousa. Dendritic cells as sensors of infection. Immunity 14(5):495-498 (2001).
34. G. Trinchieri. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2):133-146 (2003).
35. M. Della Chiesa, M. Vitale, S. Carlomagno, G. Ferlazzo, L. Moretta and A. Moretta. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33(6):1657-1666 (2003).
36. R.B. Mailliard, S.M. Alber, H. Shen, S.C. Watkins, J.M. Kirkwood, R.B. Herberman and P. Kailnski. IL-18-induced CD83+ CCR7+ NK helper cells. J Exp Med 200(7):941-953 (2005).
37. A. Kaser, S. Kaser, N.C. Kaneider, B. Enrich, C.J. Wiedermann and H. Tilg. Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2 through IL-18 receptor expression. Blood 103(2):648-655 (2004).
38. F. Gerosa, A. Gobbi, P. Zorzi, S. Burg, F. Briere, G. Carra and G. Trinchieri. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174(2):727-734 (2005).
39. C. Romagnani, M. Della Chiesa, S. Kohler, B. Moewes, A. Radbruch, L. Moretta, A. Moretta and A. Thiel. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 35(8):2452-2458 (2005).
40. D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto and A. Lanzavecchia. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31(11):3388-3393 (2001).
41. C. Asselin-Paturel and G. Trinchieri. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 202(4):461-465 (2005).
42. A.M. Krieg. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760 (2002).
43. V. Supajatura, H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra and H. Ogawa. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109(10):1351-1359 (2002).
44. M. Kulka, L. Alexopoulou, R.A. Flavell and D.D. Metcalfe. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114(1):174-182 (2004).
45. J.S. Marshall. Mast-cell responses to pathogens. Nat Rev Immunol 4(10):787-799 (2004).
46. K.P. van Gisbergen, T.B. Geijtenbeek and Y. van Kooyk. Close encounters of neutrophils and DCs. Trends Immunol 26(12):626-631 (2005).
47. H. Nagase, S. Okugawa, Y. Ota, M. Yamaguchi, H. Tomizawa, K. Matsushima, K. Ohta, K. Yamamoto and K. Hirai. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol 171(8):3977-3982 (2003).
48. M. Colonna, G. Trinchieri and Y.J. Liu. Plasmacytoid dendritic cells in immunity. Nat Immunol 5(12):1219-1226 (2004).
49. E. Marcenaro, M. Della Chiesa, F. Bellora, S. Parolini, R. Millo, L. Moretta and A. Moretta. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 174(7):3992-3998 (2005).
50. R.B. Mailliard, Y.I. Son, R. Redlinger, P.T. Coates, A. Giermasz, P.A. Morel, W.J. Storkus and P. Kalinski. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171(5):2366-2373 (2003).
51. M. Vitale, M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, L. Moretta and A. Moretta. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106(2):566-571 (2005).
52. S. Bennouna, S.K. Bliss, T.J. Curiel and E.Y. Denkers. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol 171(11):6052-6058 (2003).
53. K.P. van Gisbergen, M. Sanchez-Hernandez, T.B. Geijtenbeek and Y. van Kooyk. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med 201(8):1281-1292 (2005).
54. M.A. Cassatella. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16(1):21-26 (1995).
55. S. Bennouna and E.Y. Denkers. Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production. J Immunol 174(8):4845-4851 (2005).
56. I. Sabroe, L.R. Prince, E.C. Jones, M.J. Horsburgh, S.J. Foster, S.N. Vogel, S.K. Dower and M.K. Whyte. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 170(10):5268-5275 (2003).
57. P. Scapini, J.A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni and M.A. Cassatella. The neutrophil as a cellular source of chemokines. Immunol Rev 177:195-203 (2000).
58. S.J. Galli, S. Nakae and M. Tsai. Mast cells in the development of adaptive immune responses. Nat Immunol 6(2):135-142 (2005).
59. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens and T.P. Salazar-Mather. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189-220 (1999).
60. S.L. Constant and K. Bottomly. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15:297-322 (1997).
61. E. Marcenaro, B. Ferranti and A. Moretta. NK-DC interaction: on the usefulness of auto-aggression. Autoimmun Rev 4(8):520-525 (2005).
62. D. Dombrowicz and M. Capron. Eosinophils, allergy and parasites. Curr Opin Immunol 13(6):716-720 (2001).
63. C. Bandeira-Melo and P.F. Weller. Mechanisms of eosinophil cytokine release. Mem Inst Oswaldo Cruz 100(Suppl 1)73-81 (2005).
64. B. Lamkhioued, A.S. Gounni, D. Aldebert, E. Delaporte, L. Prin, A. Capron and M. Capron. Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann NY Acad Sci 796:203-208 (1996).
65. C. Bandeira-Melo, K. Sugiyama, L.J. Woods and P.F. Weller. Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol 166(8):4813-4817 (2001).
66. M. Grewe, W. Czech, A. Morita, T. Werfel, M. Klammer, A. Kapp, T. Ruzicka, E. Schopf and J. Krutmann. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 161(1):415-420 (1998).